Related Experiment Video

Updated: May 27, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

[Targeted therapy: the benefit of new oncological tests]

Carolien P Schröder1, Karel G M Moons, E G E Liesbeth de Vries

  • 1Universitair Medisch Centrum Groningen, afd. Medische Oncologie, Groningen, the Netherlands. c.p.schroder@umcg.nl

Nederlands Tijdschrift Voor Geneeskunde
|November 17, 2011
PubMed

Insights

Finding the right cancer treatment is crucial. New biomarkers are needed to predict targeted therapy effectiveness, sparing patients ineffective treatments and reducing costs.

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Clinical Trial Design

Context:

  • Targeted cancer therapies are rapidly advancing.
  • Predictive biomarkers are essential for personalized oncology to optimize treatment selection.
  • Current validation methods for biomarkers are time-consuming and expensive.

Purpose:

  • To highlight the need for efficient biomarker validation for targeted cancer therapies.
  • To explore alternative clinical study designs for quicker verification of predictive tests.
  • To reduce costs and side effects associated with non-effective cancer treatments.

Summary:

  • The increasing availability of targeted cancer drugs necessitates reliable biomarkers to predict treatment response in individual patients.
  • Standardized tests like oestrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) exist, but new methods are needed for gene expression profiles.
  • Efficient validation of predictive biomarkers is critical to spare patients ineffective treatments, avoid side effects, and lower healthcare costs.

Impact:

  • Facilitates personalized cancer treatment selection.
  • Reduces healthcare expenditure by avoiding non-effective therapies.
  • Accelerates the clinical adoption of novel targeted therapies and diagnostic techniques.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...